DOCUMENT

Headlines – Special Edition 14 Cerebral palsy care set to change in New Zealand New Zealand will soon have a national research platform dedicated to cerebral palsy, thanks to a Neurological Foundation platform grant of nearly $1M. The platform is an evolution of the existing cerebral palsy register, shifting our health system from simply recording births to collecting genetic, MRI and long-term data – providing answers to families and opening doors to treatments during the critical early months of life. When a baby is diagnosedwith cerebral palsy, the initial shock is often quickly followed by uncertainty. The condition is lifelong, there is no cure, andmany parents are left wonderingwhy it happened, or what the futuremay hold. That is nowbeginning tochange. Amajor new investment in cerebral palsy research, announced through theNeurological Foundation’s newPlatformGrant initiative, will helpensure babies bornwithcerebral palsy inNewZealandarenot left behindas advances in treatment emergeworldwide. Bringing together clinicians and researchers from Starship Children’s Hospital, Capital, Coast and Hutt Valley, the University of Auckland’s Liggins Institute and the Cerebral Palsy Society of New Zealand, and in partnership with the Cerebral Palsy Alliance Australia, the platform aims to help families better understand why their baby has cerebral palsy, provide earlier diagnosis, and open the door to tailored treatments. “For many parents, knowing that something is not right, but not sure what, can feel like a nightmare,” says Professor Susan Stott, a paediatric orthopaedic surgeon at Starship Children’s Hospital, who brings decades of hands-on experience caring for babies and children with cerebral palsy into the design of the study. “In cerebral palsy diagnoses, it has been verymuch a case of waiting and seeing, not making a diagnosis because of uncertainty, and therefore not knowingwhat the future holds,” Susan says, adding that the focus is now shifting towards early detection of babies at high risk of cerebral palsy. Doctors diagnosecerebral palsybyobservingpatterns of movement, postureanddevelopment over time. The signs can be subtleearlyonandoftenbecomeclearer as ababy grows. There is currently no single blood test or genetic test that confirms cerebral palsy. Once diagnosed, treatment typically focuses on managing symptoms – such as physiotherapy to support movement and development – rather than addressing the underlying drivers of the condition. “It’s not helpful to tell parents their child has cerebral palsy without being able to explain why,” Susan says. “Parents are constantly wondering whether their child will develop epilepsy, have hearing or vision problems, hip instability or a spinal curve – all things that can happen, but don’t happen to every child. Families may live with that uncertainty for years, waiting to see whether the next scan or X-ray will show a new problem,” she says. “Knowing the reason for the cerebral palsy is another step towards predicting what might happen in the future and how best to detect and treat it early.” Some of the team behind the new cerebral palsy research platform.